Moberg Pharma AB (publ) Capital Reinvestment Ratio
Moberg Pharma AB (publ) capital reinvestment ratio. Moberg Pharma AB (publ) (MOB) has a Capital Reinvestment Ratio of 1.00x as of December 2025, meaning it reinvests 1% of its operating cash flow (Skr1.52 Million) in capital expenditures (Skr1.52 Million). Check Moberg Pharma AB (publ) (MOB) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Moberg Pharma AB (publ) (2012–2019)
Capital reinvestment ratio of Moberg Pharma AB (publ) from 2012 to 2019. This chart tracks Moberg Pharma AB (publ)'s Capital Reinvestment Ratio across 6 annual periods. Also explore MOB shareholders equity momentum to track the company's year-over-year net asset growth rate.
Moberg Pharma AB (publ) Capital Reinvestment Ratio by Year (2012–2019)
Moberg Pharma AB (publ) capital reinvestment ratio by year from 2012 to 2019. For the full cash flow conversion analysis, see MOB cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.73x | Skr3.95 Million | Skr2.87 Million | ▼ -35.8% |
| 2018 | 1.13x | Skr73.89 Million | Skr83.64 Million | ▲ +209.6% |
| 2017 | 0.37x | Skr53.82 Million | Skr19.68 Million | ▼ -74.4% |
| 2015 | 1.43x | Skr30.72 Million | Skr43.88 Million | ▲ +217.5% |
| 2014 | 0.45x | Skr16.16 Million | Skr7.27 Million | ▲ +576.8% |
| 2012 | 0.07x | Skr9.48 Million | Skr630.00K | — |